By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom today said that the US District Court for the Southern District of California has approved the settlement reached in a class action suit brought by shareholders of the firm.

Under the settlement, Sequenom agreed to pay shareholders $14 million, and it agreed to issue to the plaintiffs a number of shares of Sequenom common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.